Russia has developed an mRNA cancer vaccine and plans to release it publicly in early 2025, free of charge. Pre-clinical trials show it inhibits tumor growth and spread. Researchers are also using AI to personalize cancer vaccines, potentially reducing creation time to under an hour.
